Thursday, January 22, 2026
Health & Fitness
6 min read

UK Children Screening for Type 1 Diabetes: Study Shows Effectiveness

BBC
January 21, 20261 day ago
Screening all UK children for type 1 diabetes would be effective, study says

AI-Generated Summary
Auto-generated

A large study suggests universal screening for type 1 diabetes in UK children via finger-prick tests could be effective. Early detection could prevent life-threatening diabetic ketoacidosis and allow for prompt treatment. The ELSA study, involving 17,000 children, demonstrated benefits, with one participant receiving a drug to delay diabetes onset.

All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. Currently, many young people go undiagnosed and risk developing a life-threatening complication called diabetic ketoacidosis that needs urgent hospital treatment. Identifying diabetes earlier could help avoid this and mean treatments to control problematic blood sugar levels can be given sooner. Some 17,000 children aged three to 13 have already been checked as part of the ELSA, external (Early Surveillance for Autoimmune diabetes) study, funded by diabetes charities. Imogen, who is 12 and from the West Midlands, is one of those found to have diabetes thanks to the screening. Her mum Amy says knowing what's coming, rather than being taken by surprise, has made a massive difference to their confidence and peace of mind. "Imogen took part in the study to further research and help others, but it has helped her too – being forewarned is being forearmed. "She was always going to develop type 1 diabetes, but through ELSA we've been able to slow down the process and prepare. We know what's coming, but we're not scared." Imogen is being given ongoing support to prepare her for what is to come. Amy, who is 44 and has type 1 diabetes herself, is aware of the risks with the disease. She was diagnosed aged 13 after developing diabetic ketoacidosis. "When I was diagnosed, I had no warning and ended up quite poorly in hospital," she recalls. Imogen is now trying a new type of drug designed to delay her diabetes. It's an immunotherapy called teplizumab that helps calm her immune system to slow its attack of her pancreas. In trials, external, the drug has been shown to delay the onset of diabetes by about three years, on average. It is not yet widely available on the NHS. Imogen is only the second child in the UK to get it.

Rate this article

Login to rate this article

Comments

Please login to comment

No comments yet. Be the first to comment!
    Type 1 Diabetes Screening for UK Children: Study Results